First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

Autor: RTS,S Clinical Trials Partnership, Agnandji, Selidji Todagbe, Lell, Bertrand, Soulanoudjingar, Solange Solmeheim, Fernandes, José Francisco, Abossolo, Béatrice Peggy, Conzelmann, Cornelia, Methogo, Barbara Gaelle Nfono Ondo, Doucka, Yannick, Flamen, Arnaud, Mordmüller, Benjamin, Issifou, Saadou, Kremsner, Peter Gottfried, Sacarlal, Jahit, Aide, Pedro, Lanaspa, Miguel, Aponte, John J, Nhamuave, Arlindo, Quelhas, Diana, Bassat, Quique, Mandjate, Sofia, Macete, Eusébio, Alonso, Pedro, Abdulla, Salim, Salim, Nahya, Juma, Omar, Shomari, Mwanajaa, Shubis, Kafuruki, Machera, Francisca, Hamad, Ali Said, Minja, Rose, Mtoro, Ali, Sykes, Alma, Ahmed, Saumu, Urassa, Alwisa Martin, Ali, Ali Mohammed, Mwangoka, Grace, Tanner, Marcel, Tinto, Halidou, D'Alessandro, Umberto, Sorgho, Hermann, Valea, Innocent, Tahita, Marc Christian, Kaboré, William, Ouédraogo, Sayouba, Sandrine, Yara, Guiguemdé, Robert Tinga, Ouédraogo, Jean Bosco, Hamel, Mary J, Kariuki, Simon, Odero, Chris, Oneko, Martina, Otieno, Kephas, Awino, Norbert, Omoto, Jackton, Williamson, John, Muturi-Kioi, Vincent, Laserson, Kayla F, Slutsker, Laurence, Otieno, Walter, Otieno, Lucas, Nekoye, Otsyula, Gondi, Stacey, Otieno, Allan, Ogutu, Bernhards, Wasuna, Ruth, Owira, Victorine, Jones, David, Onyango, Agnes Akoth, Njuguna, Patricia, Chilengi, Roma, Akoo, Pauline, Kerubo, Christine, Gitaka, Jesse, Maingi, Charity, Lang, Trudie, Olotu, Ally, Tsofa, Benjamin, Bejon, Philip, Peshu, Norbert, Marsh, Kevin, Owusu-Agyei, Seth, Asante, Kwaku Poku, Osei-Kwakye, Kingsley, Boahen, Owusu, Ayamba, Samuel, Kayan, Kingsley, Owusu-Ofori, Ruth, Dosoo, David, Asante, Isaac, Adjei, George, Chandramohan, Daniel, Greenwood, Brian, Lusingu, John, Gesase, Samwel, Malabeja, Anangisye, Abdul, Omari, Kilavo, Hassan, Mahende, Coline, Liheluka, Edwin, Lemnge, Martha, Theander, Thor, Drakeley, Chris, Ansong, Daniel, Agbenyega, Tsiri, Adjei, Samuel, Boateng, Harry Owusu, Rettig, Theresa, Bawa, John, Sylverken, Justice, Sambian, David, Agyekum, Alex, Owusu, Larko, Martinson, Francis, Hoffman, Irving, Mvalo, Tisungane, Kamthunzi, Portia, Nkomo, Ruthendo, Msika, Albans, Jumbe, Allan, Chome, Nelecy, Nyakuipa, Dalitso, Chintedza, Joseph, Ballou, W Ripley, Bruls, Myriam, Cohen, Joe, Guerra, Yolanda, Jongert, Erik, Lapierre, Didier, Leach, Amanda, Lievens, Marc, Ofori-Anyinam, Opokua, Vekemans, Johan, Carter, Terrell, Leboulleux, Didier, Loucq, Christian, Radford, Afiya, Savarese, Barbara, Schellenberg, David, Sillman, Marla, Vansadia, Preeti

BACKGROUND: An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. METHODS: From March 2009 through January 2011, we enrolled 15,460 children in two

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::3007e93080adaf923eb3795c29a66392
https://researchonline.lshtm.ac.uk/id/eprint/39130/1/nejmoa1102287.pdf

Efficacy and Safety of the RTS,S/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites.

Publikováno v: PLoS Medicine. Jul2014, Vol. 11 Issue 7, p1-24. 24p. 2 Diagrams, 2 Charts, 17 Graphs, 1 Map.